Vifor

RETACRIT

View Prices
  1. Home
    2.  / 
  2. Q Code
    3.  / RETACRIT – Q5106

Manufacturer:

Vifor

Name:

RETACRIT

HCPCS Code Descriptor:

Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units

Category:

Q Code

HCPCS:

Q5106

NDC(s):

59353-0220-10, 59353-0220-01, 59353-0120-10, 59353-0004-10, 59353-0010-10, 59353-0120-01, 59353-0003-10, 59353-0002-10, 00069-1318-10, 00069-1311-10, 00069-1309-04, 00069-1308-10, 00069-1307-10, 00069-1306-10, 00069-1305-10

Primary Type:

Oncology Biosimilar

Generic Status:

Multi-Source

Route of Administration:

Subcutaneous

About:

RETACRIT is an Oncology Biosimilar drug manufactured by Vifor and administered via the Subcutaneous route of administration. The Q Code: Q5106 is aligned to the drug RETACRIT.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/18

HCPCS Effective Date:

1/1/20

HCPCS Short Description:

Inj retacrit non-esrd use

Billing and Coding Guide:

Not Found

Patient Assistance:

https://www.pfizerrxpathways.com/

https://www.pfizeroncologytogether.com/